Mirko Ancillotti joined CRB in September 2013 and started his PhD in February 2016.In his PhD project he investigates perceptions, beliefs, preferences and moral views at the base of behaviour influencing antibiotic use and resistance. In 2014-2015 he worked on a research project on public understanding and media portrayal of synthetic biology.He holds a degree of Master of Arts in Philosophy from the University of Pisa in 2012. His Master thesis regarded John Harris’ influence on contemporary bioethical debate on cloning and enhancement. Mirko Ancillotti is also assistant editor of the CODEX website with rules and guidelines for research.
Phone: +46 18-471 61 71
Recently in the media
- Mirko Ancillotti & public awareness of antibiotic resistance.
The AMR Studio, 2019-03-12
Mirko Ancillotti is looking at antibiotics resistance and the ethical aspects of using peptide-based antibiotics.
Codex - Rules and guidelines for research
Media portrayal of synthetic biology
Public awareness and individual responsibility needed for judicious use of antibiotics: a qualitative study of public beliefs and perceptions
Part of BMC Public Health, 2018.
Uncritical and unbalanced coverage of synthetic biology in the Nordic press
Part of Public Understanding of Science, p. 235-250, 2017.
An Update of Public Perceptions of Synthetic Biology: Still Undecided?
Part of NanoEthics, p. 309-325, 2016.
Challenges and opportunities for ELSI early career researchers
Part of BMC Medical Ethics, 2016.
Synthetic Biology in the Press: Media Portrayal in Sweden and Italy
Part of Ambivalences of Creating Life. , p. 141-156, 2016.
John Harris. Persona, potenzialità e pre-persona
Part of Sintesi Dialettica, 2013.
The Value of the Pre-Person: Potentiality, Person-Maker Criteria, and Social Dimension
Part of Journal of Philosophy of Life, p. 190-201, 2013.
Synthetic biology, ethics and antibiotics
Who shapes public opinion of science? How do people make trade-offs between risks and benefits of technology that could both help and harm? Mirko Ancillotti is moving from media portrayal of synthetic biology to antibiotic resistance and the ethical aspects of using a new kind of peptide-based antibiotics.